neuromyelitis optica spectrum disorder

Roche trumpets data for Soliris rival in NMOSD after US, EU filings
Pharmaforum
Mon, 12/2/19 - 10:34 am
Roche
satralizumab
neuromyelitis optica spectrum disorder
NMOSD
Roche's satralizumab cuts relapse risk in rare disease phase 3
Fierce Biotech
Thu, 09/12/19 - 10:37 am
Roche
satralizumab
neuromyelitis optica spectrum disorder
Alexion aims for fourth rare disease use for blockbuster Soliris
Pharmaforum
Tue, 02/26/19 - 09:36 am
Alexion Pharmaceuticals
Soliris
neuromyelitis optica spectrum disorder